Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area

被引:3
作者
Yamai, Daisuke [1 ]
Shimada, Yoshifumi [1 ]
Nakano, Masato [1 ]
Ozeki, Hikaru [1 ]
Matsumoto, Akio [1 ]
Abe, Kaoru [1 ]
Tajima, Yosuke [1 ]
Nakano, Mae [1 ]
Ichikawa, Hiroshi [1 ]
Sakata, Jun [1 ]
Nagai, Takahiro [2 ]
Ling, Yiwei [3 ]
Okuda, Shujiro [2 ,3 ]
Watanabe, Gen [4 ]
Nogami, Hitoshi [5 ]
Maruyama, Satoshi [5 ]
Takii, Yasumasa [5 ]
Wakai, Toshifumi [1 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, 1-757 Asahimachi Dori,Chuo Ku, Niigata, Niigata 9518510, Japan
[2] Niigata Univ Med & Dent Hosp, Ctr Genom Data Management, Niigata, Niigata 9518520, Japan
[3] Niigata Univ, Med AI Ctr, Sch Med, Niigata, Niigata 9518514, Japan
[4] Niigata Canc Ctr Hosp, Dept Pathol, Niigata, Niigata 9518566, Japan
[5] Niigata Canc Ctr Hosp, Dept Surg, Niigata, Niigata 9518566, Japan
关键词
Lateral pelvic lymph node area; Lateral pelvic lymph node dissection; Low rectal cancer; Rectal cancer; Tumor deposit; COLON-CANCER; DISSECTION; IMPROVE;
D O I
10.1007/s10147-023-02391-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundAlthough previous studies have demonstrated that tumor deposits (TDs) are associated with worse prognosis in colon cancer, their clinical significance in rectal cancer has not been fully elucidated, especially in the lateral pelvic lymph node (LPLN) area. This study aimed to clarify the clinical significance of TDs, focusing on the number of metastatic foci, including lymph node metastases (LNMs) and TDs, in the LPLN area.MethodsThis retrospective study involved 226 consecutive patients with cStage II/III low rectal cancer who underwent LPLN dissection. Metastatic foci, including LNM and TD, in the LPLN area were defined as lateral pelvic metastases (LP-M) and were evaluated according to LP-M status: presence (absence vs. presence), histopathological classification (LNM vs. TD), and number (one to three vs. four or more). We evaluated the relapse-free survival of each model and compared them using the Akaike information criterion (AIC) and Harrell's concordance index (c-index).ResultsForty-nine of 226 patients (22%) had LP-M, and 15 patients (7%) had TDs. The median number of LP-M per patient was one (range, 1-9). The best risk stratification power was observed for number (AIC, 758; c-index, 0.668) compared with presence (AIC, 759; c-index, 0.665) and histopathological classification (AIC, 761; c-index, 0.664). The number of LP-M was an independent prognostic factor for both relapse-free and overall survival, and was significantly associated with cumulative local recurrence.ConclusionThe number of metastatic foci, including LNMs and TDs, in the LPLN area is useful for risk stratification of patients with low rectal cancer.
引用
收藏
页码:1388 / 1397
页数:10
相关论文
共 31 条
  • [1] Akaike H., 1973, 2 INT S INFORM THEOR, P267
  • [2] Selective Lateral Pelvic Lymph Node Dissection in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy Based on Pretreatment Imaging
    Akiyoshi, Takashi
    Ueno, Masashi
    Matsueda, Kiyoshi
    Konishi, Tsuyoshi
    Fujimoto, Yoshiya
    Nagayama, Satoshi
    Fukunaga, Yosuke
    Unno, Toshiyuki
    Kano, Atsuhiro
    Kuroyanagi, Hiroya
    Oya, Masatoshi
    Yamaguchi, Toshiharu
    Watanabe, Toshiaki
    Muto, Tetsuichiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (01) : 189 - 196
  • [3] Results of a Japanese Nationwide Multi-Institutional Study on Lateral Pelvic Lymph Node Metastasis in Low Rectal Cancer Is It Regional or Distant Disease?
    Akiyoshi, Takashi
    Watanabe, Toshiaki
    Miyata, Satoshi
    Kotake, Kenjiro
    Muto, Tetsuichiro
    Sugihara, Kenichi
    [J]. ANNALS OF SURGERY, 2012, 255 (06) : 1129 - 1134
  • [4] Amin MB., 2017, AJCC CANC STAGING MA, DOI DOI 10.1007/978-3-319-40618-3
  • [5] Verification of the Japanese staging system for rectal cancer, focusing on differences with the TNM classification
    Arabiki, Michiru
    Shimada, Yoshifumi
    Nakano, Mae
    Tanaka, Kana
    Oyanagi, Hidehito
    Nakano, Masato
    Ling, Yiwei
    Okuda, Shujiro
    Takii, Yasumasa
    Wakai, Toshifum
    [J]. SURGERY TODAY, 2020, 50 (11) : 1443 - 1451
  • [6] Tumor deposits improve staging in colon cancer: what are the next steps?
    Brouwer, N. P. M.
    Nagtegaal, I. D.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 (10) : 1209 - 1211
  • [7] Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)
    Cohen, R.
    Shi, Q.
    Meyers, J.
    Jin, Z.
    Svrcek, M.
    Fuchs, C.
    Couture, F.
    Kuebler, P.
    Ciombor, K. K.
    Bendell, J.
    De Jesus-Acosta, A.
    Kumar, P.
    Lewis, D.
    Tan, B.
    Bertagnolli, M. M.
    Philip, P.
    Blanke, C.
    O'Reilly, E. M.
    Shields, A.
    Meyerhardt, J. A.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 (10) : 1267 - 1275
  • [8] A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification
    Delattre, Jean-Francois
    Erdogan, Ayse Selcen Oguz
    Cohen, Romain
    Shi, Qian
    Emile, Jean-Francois
    Taieb, Julien
    Tabernero, Josep
    Andre, Thierry
    Meyerhardt, Jeffrey A.
    Nagtegaal, Iris D.
    Svrcek, Magali
    [J]. CANCER TREATMENT REVIEWS, 2022, 103
  • [9] Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)
    Delattre, Jean-Francois
    Cohen, Romain
    Henriques, Julie
    Falcoz, Antoine
    Emile, Jean-Francois
    Fratte, Serge
    Chibaudel, Benoist
    Dauba, Jerome
    Dupuis, Olivier
    Becouarn, Yves
    Bibeau, Frederic
    Taieb, Julien
    Louvet, Christophe
    Vernerey, Dewi
    Andre, Thierry
    Svrcek, Magali
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15) : 1702 - +
  • [10] Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial
    Fujita, Shin
    Akasu, Takayuki
    Mizusawa, Junki
    Saito, Norio
    Kinugasa, Yusuke
    Kanemitsu, Yukihide
    Ohue, Masayuki
    Fujii, Shoichi
    Shiozawa, Manabu
    Yamaguchi, Takashi
    Moriya, Yoshihiro
    [J]. LANCET ONCOLOGY, 2012, 13 (06) : 616 - 621